Heart Cash Conversion Cycle from 2010 to 2024

HSCS Stock  USD 2.67  0.05  1.91%   
Heart Test Cash Conversion Cycle yearly trend continues to be comparatively stable with very little volatility. Cash Conversion Cycle will likely drop to 5,434 in 2024. From the period from 2010 to 2024, Heart Test Cash Conversion Cycle quarterly data regression had mean square error of 11.3 M and mean deviation of  2,197. View All Fundamentals
 
Cash Conversion Cycle  
First Reported
2010-12-31
Previous Quarter
10.9 K
Current Value
5.4 K
Quarterly Volatility
3.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heart Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heart Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 58.5 K, Interest Expense of 242.9 K or Selling General Administrative of 2.5 M, as well as many indicators such as Price To Sales Ratio of 349, Dividend Yield of 0.0 or PTB Ratio of 0.42. Heart financial statements analysis is a perfect complement when working with Heart Test Valuation or Volatility modules.
  
Check out the analysis of Heart Test Correlation against competitors.

Latest Heart Test's Cash Conversion Cycle Growth Pattern

Below is the plot of the Cash Conversion Cycle of Heart Test Laboratories over the last few years. It is Heart Test's Cash Conversion Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heart Test's overall financial position and show how it may be relating to other accounts over time.
Cash Conversion Cycle10 Years Trend
Slightly volatile
   Cash Conversion Cycle   
       Timeline  

Heart Cash Conversion Cycle Regression Statistics

Arithmetic Mean4,975
Coefficient Of Variation69.33
Mean Deviation2,197
Median3,914
Standard Deviation3,449
Sample Variance11.9M
Range15.1K
R-Value0.34
Mean Square Error11.3M
R-Squared0.12
Significance0.21
Slope263.43
Total Sum of Squares166.6M

Heart Cash Conversion Cycle History

2024 5433.54
202310.9 K
2022 5873.16
2021 -894.31
202014.2 K

About Heart Test Financial Statements

Heart Test shareholders use historical fundamental indicators, such as Cash Conversion Cycle, to determine how well the company is positioned to perform in the future. Although Heart Test investors may analyze each financial statement separately, they are all interrelated. The changes in Heart Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Heart Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Conversion Cycle10.9 K5.4 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.